Go Pro

NovoCure (NVCR) Insider Trading & Ownership

NovoCure logo
$17.53 +0.58 (+3.42%)
As of 08/17/2026 04:00 PM Eastern

NovoCure (NASDAQ:NVCR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.55%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$996.54K
Number Of
Insiders Selling
(Last 12 Months)
12
Amount Of
Insider Selling
(Last 12 Months)
$2.75M
Get NVCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVCR Insider Buying and Selling by Quarter

NovoCure Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/4/2026Sell34,273$17.93$614,514.89  
6/2/2026Sell2,945$15.77$46,442.65  
6/2/2026Sell2,945$15.77$46,442.65  
6/2/2026Sell2,945$15.77$46,442.65  
6/2/2026Sell2,945$15.77$46,442.65  
6/2/2026Sell2,945$15.77$46,442.65  
6/2/2026Sell2,945$15.77$46,442.65  
3/5/2026Sell43,246$13.77$595,497.42  
3/4/2026Sell6,412$13.31$85,343.72  
3/4/2026Sell5,607$13.31$74,629.17  
Iran War: What Happened at 1:11 P.M. Outside D.C.? (Ad)

A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 trillion dollar financial story unfolding behind the Iran conflict. Addison Wiggin, founder of the Grey Swan Investment Fraternity, investigated the claims himself and found enough corroboration to bring the story forward. The full account follows the money behind the headlines and shows why the Iran situation may look very different than reported.tc pixel

See the full investigation into the Iran money trail now
3/4/2026Sell1,100$13.31$14,641.00  
3/4/2026Sell5,377$13.31$71,567.87  
3/4/2026Sell6,412$13.31$85,343.72  
3/3/2026Sell71,887$12.98$933,093.26  
9/5/2025Buy81,550$12.22$996,541.00  
(Data available from 1/1/2013 forward)

NVCR Insider Trading Activity - Frequently Asked Questions

6.55% of NovoCure stock is owned by insiders. Learn more on NVCR's insider holdings.

The following insiders have purchased NVCR shares in the last 24 months: Ashley Cordova ($996,541.00), and Christoph Brackmann ($231,800.00).

Insiders have purchased a total of 101,550 NVCR shares in the last 24 months for a total of $1,228,341.00 bought.

The following insiders have sold NVCR shares in the last 24 months: Allyson J Ocean ($46,442.65), Christoph Brackmann ($85,343.72), Frank X Leonard ($698,676.18), Gabriel Leung ($46,442.65), Jeryl L Hilleman ($46,442.65), Kristin Stafford ($46,442.65), Michal Nath Puri ($27,430.90), Mukund Paravasthu ($669,606.09), Timothy J Scannell ($46,442.65), Uri Weinberg ($85,343.72), W Anthony Vernon ($46,442.65), and William F Doyle ($933,093.26).

Insiders have sold a total of 193,552 NovoCure shares in the last 24 months for a total of $2,778,149.77 sold.



This page (NASDAQ:NVCR) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners